BeStock  
Stocks › Biotechnology › APMD

Apnimed APMD

US equityMarket cap rank #3458Biotechnology
$18.04 −$0.61 (-3.27%)
Pre-market · Oct 8, 8:20 am ET · After hours $18.04 0.00%
Open$18.66
Prev close$18.65
Day range$17.84 – $19.40
Volume465.6K
Market cap$751.02M
P/E (TTM)4.6
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$12.08M-29.4% YoY
Operating profit-$11.70M-97.2% YoY
Net profit$125.94M+281.3% YoY
Diluted EPS$3.16+230.9% YoY
Free cash flow-$18.45M-6.2% YoY
Operating cash flow-$18.11M

Revenue, last 4 quarters

$3.1MMar '25$17.1MJun '25$84.8MMar '26$12.1MJun '26

Net profit, last 4 quarters

$-28.6MMar '25$-69.5MJun '25$70.4MMar '26$125.9MJun '26

Diluted EPS by quarter

-1.00Mar '25-2.42Jun '252.12Mar '263.16Jun '26

Free cash flow by quarter

$-28.5MMar '25$-17.4MJun '25$-19.8MMar '26$-18.4MJun '26

Profitability & balance sheet

Gross margin93.9%
Operating margin30.9%
Net margin252.6%
Return on assets148.8%
Current ratio5.19
Liabilities / assets190.1%
Cash & investments$172.80M
Total debt$80.08M
Net cash (debt)$92.72M

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2024 ANNUAL
-Cash and Cash Equivalents $172.80M $328.88M $41.89M $68.35M
Cash and Cash Equivalents & Short-Term Investments $172.80M $328.88M $41.89M $68.35M
Total Current Assets $184.77M $332.00M $45.06M $73.25M
Total Assets $195.46M $342.63M $72.87M $109.22M
-Common Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00
Capital Stock $1,000.00 $1,000.00 $1,000.00 $1,000.00
Stockholders' Equity -$176.18M $257.59M -$372.78M -$248.62M
Total Equity -$176.18M $257.59M -$372.78M -$248.62M
Other Non-Current Liabilities $10.04M – $57.12M $64.36M
Convertible preferred securities $245.94M $0.00 $221.15M $204.89M
Non-Current Deferred Liabilities $0.00 $0.00 $15.24M $45.36M
-Long Term Capital Lease Obligation $485,000.00 $555,000.00 $623,000.00 $873,000.00
-Long Term Debt $79.60M $46.10M $40.65M –
Long Term Debt and Capital Lease Obligation $80.08M $46.66M $41.27M $873,000.00
Total Non-Current Liabilities $336.06M $46.66M $334.78M $315.48M
Other Current Liabilities $179,000.00 – $86,000.00 $152,000.00
Current Deferred Liabilities $19.53M $30.40M $97.81M $25.00M
-Current Capital Lease Obligation $265,000.00 $257,000.00 $250,000.00 $222,000.00
Short-Term Debt and Capital Lease Obligation $265,000.00 $257,000.00 $250,000.00 $222,000.00
Total Current Liabilities $35.58M $38.39M $110.88M $42.36M
Additional Paid-In Capital $27.51M $444.56M $24.56M $20.54M
Retained Earnings -$203.69M -$186.97M -$397.34M -$269.15M
Current Accrued Expenses $4.91M $4.72M $4.39M $7.40M
-Accounts Payable $6.60M $3.01M $1.79M $3.59M
Payables $6.60M $3.01M $1.79M $3.59M
Total Non-Current Assets $10.68M $10.64M $27.82M $35.98M
Net PPE $10.66M $10.61M $901,000.00 $1.16M
Other Non-Current Assets $24,000.00 $24,000.00 $26.92M $34.82M
Other Current Assets $5.09M $346,000.00 $665,000.00 $349,000.00
Current Deferred Assets $4.78M – – –
-Accumulated Depreciation -$64,000.00 – -$51,000.00 -$24,000.00
-Accounts Receivable $690,000.00 $876,000.00 $959,000.00 $1.12M
Receivables $690,000.00 $876,000.00 $959,000.00 $1.12M
Total Liabilities $371.64M $85.04M $445.66M $357.84M
-Gross PPE $10.72M $10.61M $952,000.00 $1.18M
Prepaid Assets $1.41M $1.89M $1.54M $3.43M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q2 2025 Q1
Net Cash Flow from Continuing Financing Activities $44.37M $24.81M $51.37M $16.29M $0.00
Financing Cash Flow $44.37M $24.81M $51.37M $16.29M $0.00
-Change In Other Working Capital -$10.87M -$82.65M -$19.54M -$3.15M -$1.82M
-Change in Other Current Liabilities -$57.18M -$61,000.00 -$7.46M -$7.29M -$53,000.00
-Change in Payables and Accrued Expense $2.46M -$2.49M -$4.33M -$2.59M -$1.87M
Net Preferred Stock Issuance $48.19M $25.00M $16.50M $16.50M $0.00
Proceeds from Stock Option Exercised $812,000.00 $16,000.00 $115,000.00 $36,000.00 $0.00
Free Cash Flow -$18.45M -$19.81M -$77.83M -$17.37M -$28.45M
Beginning Cash Balance $46.89M $41.89M $68.35M $39.90M $68.35M
Ending Cash Balance $172.80M $46.89M $41.89M $38.82M $39.90M
Net Other Financing Charges -$2.85M -$208,000.00 -$243,000.00 – –
-Change in Receivables $186,000.00 $83,000.00 $156,000.00 $7,000.00 $153,000.00
Change in Working Capital -$65.75M -$89.07M -$29.59M -$12.67M -$2.64M
Other Non-Cash Items $2.91M $61,000.00 $230,000.00 $57,000.00 $55,000.00
Depreciation & Depletion & Amortization $7,000.00 $6,000.00 $27,000.00 $6,000.00 $7,000.00
Net Income from Continuing Operations $126.11M $70.37M -$58.05M -$5.63M -$26.68M
Net cash flow from continuing operations -$18.11M -$19.81M -$77.83M -$17.37M -$28.45M
-Change in Prepaid Assets -$342,000.00 -$3.95M $1.58M $347,000.00 $950,000.00
Operating Cash Flow -$18.11M -$19.81M -$77.83M -$17.37M -$28.45M
Net Change in Cash $125.92M $5.00M -$26.46M -$1.08M -$28.45M
Net cash flow from investing – – $0.00 – –
Net Cash Flow from Continuing Investing Activities – – $0.00 – –
Net PPE Purchase and Sale – – $0.00 – –
Net Investment Purchase and Sale – – $0.00 – –
Net Issuance Payments Of Debt – – $35.00M – –

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q2 2025 Q1
Total Revenue as Reported $12.08M $38.47M $38.47M $17.11M $3.13M
Total Operating Revenue $12.08M $84.81M $38.47M $17.11M $3.13M
Cost of Revenue $1.21M $2.16M $6.69M $1.72M $1.32M
Gross Profit $10.87M $82.65M $31.77M $15.39M $1.81M
Operating Expense $22.57M $14.61M $85.59M $21.32M $28.93M
Net Profit $125.94M $70.37M -$932,000.00 -$69.47M -$28.65M
Selling and Admin Expenses $12.67M $6.51M $23.49M $5.35M $5.47M
-Selling & Marketing Expense $4.83M – – $859,000.00 $730,000.00
-General & Admin Expense $7.85M $6.51M $23.49M $4.49M $4.74M
Net Income to Parent Company $125.94M $70.37M -$932,000.00 -$69.47M -$28.65M
Net Income to Common Stockholders $125.94M $70.37M -$932,000.00 -$69.47M -$28.65M
Basic EPS $3.16 $2.45 -$0.03 -$2.42 -$1.00
Diluted EPS $3.16 $2.12 -$0.03 -$2.42 -$1.00
Net Income from Discontinuous Operations -$178,000.00 – – -$63.85M -$1.97M
Profit from Continuing Operations $126.11M $70.37M -$932,000.00 -$5.63M -$26.68M
Research & Development $9.90M $8.10M $62.10M $15.97M $23.46M
Net Non-Operating Interest Income (Expense) $970,000.00 $218,000.00 $1.41M $309,000.00 $431,000.00
Non-Operating Interest Income $970,000.00 $218,000.00 $1.41M $309,000.00 $431,000.00
Other Income (Expense) $136.85M $2.11M $51.47M – –
Special Income (Charges) $85.38M – – $0.00 –
-Gain on Sale Of Business $85.38M – – $0.00 –
Other Non-Operating Income (Expenses) $51.47M $2.11M $51.47M – –
Pretax Profit $126.11M $70.37M -$932,000.00 -$5.63M -$26.68M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Operating Profit -$11.70M $68.04M -$53.82M -$5.94M -$27.11M

Discussion

No comments yet — be the first to weigh in on APMD.

Leave a comment

Scroll to Top